PMID- 24138564 OWN - NLM STAT- MEDLINE DCOM- 20140910 LR - 20221207 IS - 1557-8518 (Electronic) IS - 1540-4196 (Linking) VI - 12 IP - 1 DP - 2014 Feb TI - The presence of at least three alleles of the ADRB3 Trp64Arg (C/T) and UCP1 -3826A/G polymorphisms is associated with protection to overweight/obesity and with higher high-density lipoprotein cholesterol levels in Caucasian-Brazilian patients with type 2 diabetes. PG - 16-24 LID - 10.1089/met.2013.0077 [doi] AB - BACKGROUND: We investigated whether the -3826A/G polymorphism (rs1800592) of the uncoupling protein 1 gene (UCP1) and the Trp64Arg polymorphism (rs4994) of the beta3-adrenergic receptor gene (ADRB3) are associated with type 2 diabetes mellitus (T2DM) and features of metabolic syndrome in a Brazilian-Caucasian population. METHODS: Both polymorphisms were genotyped in 1015 T2DM patients and 561 nondiabetic subjects. The combined effect of both polymorphisms on T2DM and metabolic syndrome-related parameters was analyzed according to a triallelic inheritance pattern, by which at least three minor alleles from two loci are necessary for trait manifestation. RESULTS: UCP1 -3826A/G and ADRB3 Trp64Arg polymorphisms were not associated with T2DM (P>0.05). Patients carrying the ADRB3 64Arg allele had higher fasting plasma glucose and high-density lipoprotein cholesterol (HDL-C) than patients with the Trp64Trp genotype (P=0.0001 and P=0.015, respectively). The 64Arg allele was also associated with protection against overweight/obesity (body mass index >/= 25 kg/m(2); odds ratio [OR]=0.598; P=0.014). Interestingly, prevalence of overweight/obesity was lower among carriers of at least three minor alleles of the -3826A/G and ADRB3 Trp64Arg polymorphisms than among patients with fewer than three minor alleles (54.5% vs. 79.1%; OR=0.288; P=0.007, respectively). Subjects with at least three minor alleles also had higher HDL-C levels (P=0.018). CONCLUSIONS: UCP1 -3826A/G and ADRB3 Trp64Arg polymorphisms may have a combined effect in the modulation of overweight/obesity and HDL-C levels in type 2 diabetes mellitus (T2DM) Caucasian-Brazilian patients. FAU - Brondani, Leticia A AU - Brondani LA AD - Endocrine Division, Hospital de Clinicas de Porto Alegre , Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil . FAU - Duarte, Guilherme C K AU - Duarte GC FAU - Canani, Luis H AU - Canani LH FAU - Crispim, Daisy AU - Crispim D LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20131018 PL - United States TA - Metab Syndr Relat Disord JT - Metabolic syndrome and related disorders JID - 101150318 RN - 0 (ADRB3 protein, human) RN - 0 (Blood Glucose) RN - 0 (Cholesterol, HDL) RN - 0 (Ion Channels) RN - 0 (Mitochondrial Proteins) RN - 0 (Receptors, Adrenergic, beta-3) RN - 0 (UCP1 protein, human) RN - 0 (Uncoupling Protein 1) SB - IM MH - Aged MH - Alleles MH - Blood Glucose MH - Brazil MH - Cholesterol, HDL/*blood MH - Diabetes Mellitus, Type 2/blood/ethnology/*genetics MH - Female MH - Genetic Predisposition to Disease MH - Genotype MH - Humans MH - Ion Channels/*genetics MH - Male MH - Metabolic Syndrome/blood/ethnology/genetics MH - Middle Aged MH - Mitochondrial Proteins/*genetics MH - Obesity/*genetics MH - Odds Ratio MH - Overweight/*genetics MH - Polymorphism, Genetic MH - Receptors, Adrenergic, beta-3/*genetics MH - Risk Factors MH - Surveys and Questionnaires MH - Uncoupling Protein 1 MH - White People EDAT- 2013/10/22 06:00 MHDA- 2014/09/11 06:00 CRDT- 2013/10/22 06:00 PHST- 2013/10/22 06:00 [entrez] PHST- 2013/10/22 06:00 [pubmed] PHST- 2014/09/11 06:00 [medline] AID - 10.1089/met.2013.0077 [doi] PST - ppublish SO - Metab Syndr Relat Disord. 2014 Feb;12(1):16-24. doi: 10.1089/met.2013.0077. Epub 2013 Oct 18.